table of content
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Diagnostics and Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Treatment Method
1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnostics and Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Diagnostics and Therapy Overall Market Size
2.1 Global Prostate Cancer Diagnostics and Therapy Market Size: 2022 VS 2030
2.2 Global Prostate Cancer Diagnostics and Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Diagnostics and Therapy Players in Global Market
3.2 Top Global Prostate Cancer Diagnostics and Therapy Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnostics and Therapy Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnostics and Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Diagnostics and Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnostics and Therapy Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnostics and Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics and Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Treatment Method - Global Prostate Cancer Diagnostics and Therapy Market Size Markets, 2022 & 2030
4.1.2 Androgen Receptor-Directed Therapy
4.1.3 Taxane-Based Chemotherapy
4.2 By Treatment Method - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
4.2.1 By Treatment Method - Global Prostate Cancer Diagnostics and Therapy Revenue, 2018-2023
4.2.2 By Treatment Method - Global Prostate Cancer Diagnostics and Therapy Revenue, 2023-2030
4.2.3 By Treatment Method - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Diagnostics and Therapy Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue, 2023-2030
5.2.3 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Prostate Cancer Diagnostics and Therapy Market Size, 2022 & 2030
6.2 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue, 2023-2030
6.2.3 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Prostate Cancer Diagnostics and Therapy Revenue, 2018-2030
6.3.2 US Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.3.3 Canada Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.3.4 Mexico Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Diagnostics and Therapy Revenue, 2018-2030
6.4.2 Germany Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.4.3 France Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.4.4 U.K. Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.4.5 Italy Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.4.6 Russia Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.4.8 Benelux Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Diagnostics and Therapy Revenue, 2018-2030
6.5.2 China Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.5.3 Japan Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.5.4 South Korea Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.5.6 India Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Prostate Cancer Diagnostics and Therapy Revenue, 2018-2030
6.6.2 Brazil Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.6.3 Argentina Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnostics and Therapy Revenue, 2018-2030
6.7.2 Turkey Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.7.3 Israel Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.7.5 UAE Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
7 Players Profiles
7.1 Ipsen SA
7.1.1 Ipsen SA Corporate Summary
7.1.2 Ipsen SA Business Overview
7.1.3 Ipsen SA Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.1.4 Ipsen SA Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.1.5 Ipsen SA Key News
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Corporate Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.2.4 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.2.5 Pfizer Inc. Key News
7.3 Johnson & Johnson Services Inc.
7.3.1 Johnson & Johnson Services Inc. Corporate Summary
7.3.2 Johnson & Johnson Services Inc. Business Overview
7.3.3 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.3.4 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Services Inc. Key News
7.4 Bayer AG
7.4.1 Bayer AG Corporate Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.4.4 Bayer AG Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.4.5 Bayer AG Key News
7.5 Abbvie Inc.
7.5.1 Abbvie Inc. Corporate Summary
7.5.2 Abbvie Inc. Business Overview
7.5.3 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.5.4 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.5.5 Abbvie Inc. Key News
7.6 Merck & Co. Inc.
7.6.1 Merck & Co. Inc. Corporate Summary
7.6.2 Merck & Co. Inc. Business Overview
7.6.3 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.6.4 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.6.5 Merck & Co. Inc. Key News
7.7 AstraZeneca PLC
7.7.1 AstraZeneca PLC Corporate Summary
7.7.2 AstraZeneca PLC Business Overview
7.7.3 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.7.4 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca PLC Key News
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Corporate Summary
7.8.2 Thermo Fisher Scientific Business Overview
7.8.3 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.8.4 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.8.5 Thermo Fisher Scientific Key News
7.9 Dendreon Pharmaceuticals LLC
7.9.1 Dendreon Pharmaceuticals LLC Corporate Summary
7.9.2 Dendreon Pharmaceuticals LLC Business Overview
7.9.3 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.9.4 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.9.5 Dendreon Pharmaceuticals LLC Key News
7.10 F. Hoffmann-La Roche Ltd
7.10.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.10.2 F. Hoffmann-La Roche Ltd Business Overview
7.10.3 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.10.4 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.10.5 F. Hoffmann-La Roche Ltd Key News
7.11 Hologic Inc.
7.11.1 Hologic Inc. Corporate Summary
7.11.2 Hologic Inc. Business Overview
7.11.3 Hologic Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.11.4 Hologic Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.11.5 Hologic Inc. Key News
7.12 Astellas Pharma Inc.
7.12.1 Astellas Pharma Inc. Corporate Summary
7.12.2 Astellas Pharma Inc. Business Overview
7.12.3 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.12.4 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.12.5 Astellas Pharma Inc. Key News
7.13 Koninklijke Philips NV
7.13.1 Koninklijke Philips NV Corporate Summary
7.13.2 Koninklijke Philips NV Business Overview
7.13.3 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.13.4 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.13.5 Koninklijke Philips NV Key News
7.14 Sanofi-Aventis
7.14.1 Sanofi-Aventis Corporate Summary
7.14.2 Sanofi-Aventis Business Overview
7.14.3 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.14.4 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.14.5 Sanofi-Aventis Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
